Bradley Thompson

Dr. Bradley G.
Thompson is an Independent Director at Zenith Capital Corp.
(Alberta), a Chief Executive Officer at Kickshaw Ventures Ltd., a Chairman & Chief Technology Officer at Cellastra, Inc., a Chief Executive Officer at Avamab Pharma, Inc. and a Chief Executive Officer at Wyvern Pharmaceuticals, Inc. He is on the Board of Directors at Zenith Capital Corp.
(Alberta).
Dr. Thompson was previously employed as an Independent Director by Enveric Biosciences, Inc., an Independent Director by Aptose Biosciences, Inc., an Independent Director by IMV, Inc., a Co-Chairman, President & Chief Executive Officer by Oncolytics Biotech, Inc., a Chief Executive Officer by Iteration Energy Ltd., a Chief Executive Officer by SYNSORB Biotech, Inc., and a Chairman-Emeritus by BIOTECanada.
He also served on the board at MagicMed Industries, Inc., E3 Lithium Ltd. and Reviva Pharmaceuticals, Inc. He received his undergraduate degree from the University of Alberta and a doctorate degree from the University of Western Ontario.